← Back to Search

Behavioral Intervention

Disclosure Intervention for Opioid Use Disorder

N/A
Recruiting
Research Sponsored by University of Delaware
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Must not have
Diagnosis of schizophrenia
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to test a disclosure intervention for people in treatment for opioid use disorder to see if it improves their treatment and recovery outcomes one year later. Participants will undergo a brief intervention to help them disclose

Who is the study for?
This trial is for individuals currently in treatment for opioid use disorder at Brandywine Counseling & Community Services, who are considering sharing their history of opioid use or treatment with someone new. It's not open to those diagnosed with schizophrenia or those who participated in the pilot study of this intervention.
What is being tested?
The trial tests a 'disclosure intervention' designed to help participants disclose their opioid use disorder and build related skills. Outcomes will be compared against a waitlist group, who'll receive the intervention after the study concludes.
What are the potential side effects?
Since this is a behavioral intervention involving decision aids and skill-building rather than medication, traditional physical side effects are not applicable. However, emotional discomfort during disclosure processes may occur.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have been diagnosed with schizophrenia.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Illicit opioid use
Retention in treatment
Secondary study objectives
Quality of life score
Recovery capital score

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Disclosing RecoveryExperimental Treatment1 Intervention
Participants complete a one-hour disclosure intervention for people in treatment for opioid use disorder. The intervention is facilitated by a workbook and accompanying worksheet.
Group II: Waitlist ComparatorActive Control1 Intervention
Participants do not complete the disclosure intervention at their baseline appointment. They are given the opportunity to complete the disclosure intervention at their final appointment.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Disclosing Recovery: A Decision Aid and Toolkit
2021
N/A
~50

Find a Location

Who is running the clinical trial?

National Institute on Drug Abuse (NIDA)NIH
2,576 Previous Clinical Trials
3,285,935 Total Patients Enrolled
Brandywine Counseling and Community ServicesUNKNOWN
University of DelawareLead Sponsor
161 Previous Clinical Trials
25,162 Total Patients Enrolled
~320 spots leftby May 2028
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top